Luigi Cavanna

Q: What Schools Are Affiliated With Luigi Cavanna

Luigi Cavanna is affiliated with the following schools: University of Milan, University of Pavia, University of Modena and Reggio Emilia, Università Campus Bio-Medico, University of Bologna

Luigi Cavanna's AcademicInfluence.com Rankings

Luigi Cavanna

Philosophy

#11042

World Rank

#15166

Historical Rank

Logic

#7860

World Rank

#9772

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Luigi Cavanna's Degrees

Doctorate Medicine University of Milan
PhD Biomedical Sciences University of Bologna

Why Is Luigi Cavanna Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Luigi Cavanna is an Italian doctor. He is the head of the hematology and oncology ward at the Guglielmo da Saliceto hospital in Piacenza, Emilia-Romagna. COVID-19 pandemic During the second week of March 2020, in the beginning of the pandemic lockdown in Italy, Cavanna realized that too many critically-ill COVID-19 patients were arriving at his hospital and that they could have been treated earlier before the escalation of the symptoms. He therefore became one of the first doctors in Italy to focus on house calls for COVID-19 patients.

(See a Problem?)

Luigi Cavanna's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study. (2009) (563)
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. (2010) (294)
Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature. (2015) (281)
Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: results of the randomized phase II CHER-LOB study. (2012) (278)
Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience. (2005) (248)
Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. (1995) (237)
Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study (2017) (205)
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. (2005) (154)
Complications of ultrasonically guided fine-needle abdominal biopsy. Results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group. (1989) (149)
Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles (2004) (135)
Randomized Trial of Low-Dose Morphine Versus Weak Opioids in Moderate Cancer Pain. (2016) (126)
Ultrasound‐guided fine needle biopsy of the spleen: High clinical efficacy and low risk in a multicenter Italian study (2001) (119)
Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer (2016) (117)
Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life. (2016) (110)
Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study‡ (2018) (108)
Study of prognosis in Waldenström's macroglobulinemia: a proposal for a simple binary classification with clinical and investigational utility. (1994) (106)
Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia. (1998) (105)
Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following moderately emetogenic chemotherapy: a randomized, multicenter, phase III trial (2010) (99)
Association between hepatitis C virus and non-Hodgkin's lymphoma, and effects of viral infection on histologic subtype and clinical course. (1999) (95)
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir (2005) (93)
Ultrasound-guided central venous catheterization in cancer patients improves the success rate of cannulation and reduces mechanical complications: A prospective observational study of 1,978 consecutive catheterizations (2010) (90)
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial. (2015) (90)
Metastatic Breast Cancer to the Gastrointestinal Tract: Report of Five Cases and Review of the Literature (2012) (89)
Are strong opioids equally effective and safe in the treatment of chronic cancer pain? A multicenter randomized phase IV 'real life' trial on the variability of response to opioids. (2016) (88)
Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey (2020) (88)
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (2020) (87)
Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy) (2020) (73)
Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study) (2010) (65)
Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw (2011) (63)
Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial (2018) (62)
Oxaliplatin in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV) in Patients With Metastatic Gastric Cancer (MGC) (2006) (60)
Ultrasound guidance reduces pneumothorax rate and improves safety of thoracentesis in malignant pleural effusion: report on 445 consecutive patients with advanced cancer (2014) (59)
Incidence of gallstones in a population of patients with cirrhosis. (1994) (59)
Ultrasonically guided fine-needle aspiration biopsy: a highly diagnostic procedure for hepatic tumors. (1990) (54)
Ultrasonically guided percutaneous splenic tissue core biopsy in patients with malignant lymphomas (1992) (54)
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer (2019) (53)
Deep femoral lymphadenectomy with preservation of the fascia lata. Preliminary report on 42 invasive vulvar carcinomas. (1990) (52)
Role of image-guided fine-needle aspiration biopsy in the management of patients with splenic metastasis (2007) (50)
High grade B-cell gastric lymphoma with complete pathologic remission after eradication of helicobacter pylori infection: Report of a case and review of the literature (2008) (50)
Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders (2004) (49)
Role of ultrasound guided fine needle aspiration biopsy in the diagnosis of hepatocellular carcinoma. (1990) (47)
Value of rapid staining and assessment of ultrasound-guided fine needle aspiration biopsies. (1988) (47)
Topographic distribution of groin lymph nodes. A study of 50 female cadavers. (1990) (46)
Lytic bone lesions suspected for metastasis: Ultrasonically guided fine‐needle aspiration biopsy (1994) (46)
Small (< or = 3 cm) hepatic lesions. Results of sonographically guided fine-needle biopsy in 385 patients. (1994) (45)
Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature (2018) (44)
Double-blind, placebo-controlled, multicenter, randomized, phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal hormone receptor-positive, human epidermal growth factor receptor 2-negative, operable breast cancer. (2014) (44)
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study. (2013) (44)
Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma (1990) (41)
COVID-19 vaccines in adult cancer patients with solid tumours undergoing active treatment: Seropositivity and safety. A prospective observational study in Italy (2021) (40)
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trial. (2015) (40)
Primary pancreatic lymphoma. A report of five cases. (2005) (39)
Cirrhosis of the liver (1990) (39)
High prevalence of antibodies to hepatitis C virus in patients with lymphoproliferative disorders. (1995) (37)
Final results of a phase II randomized trial of neoadjuvant anthracycline-taxane chemotherapy plus lapatinib, trastuzumab, or both in HER2-positive breast cancer (CHER-LOB trial). (2011) (37)
Human herpesvirus 8-associated primary effusion lymphoma in HIV--patients: a clinicopidemiologic variant resembling classic Kaposi's sarcoma. (2002) (36)
Safety and Efficacy of Enoxaparin Treatment in Venous Thromboembolic Disease during Acute Leukemia (2004) (34)
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study. (2019) (34)
Focal liver lesions in non-Hodgkin's lymphoma: investigation of their prevalence, clinical significance and the role of Hepatitis C virus infection. (2002) (34)
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group. (1993) (33)
Immune checkpoint inhibitors in EGFR-mutation positive TKI-treated patients with advanced non-small-cell lung cancer network meta-analysis (2019) (33)
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials. (2018) (32)
Impact of Pre-Treatment Lactate Dehydrogenase Levels on Prognosis and Bevacizumab Efficacy in Patients with Metastatic Colorectal Cancer (2015) (30)
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? (2014) (30)
Primary lymphoma of the spleen. Report of a case with diagnosis by fine-needle guided biopsy. (1995) (30)
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? (2014) (30)
The deep impact of novel CoVID-19 infection in an Orthopedics and Traumatology Department: the experience of the Piacenza Hospital (2020) (28)
Diagnosis of hepatic lesions: ultrasonically guided fine needle biopsy or laparoscopy? (1988) (28)
Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi. (2003) (27)
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL). (1995) (27)
COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis (2021) (27)
Ultrasonically guided fine-needle biopsy: a new useful technique in pathological staging of malignant lymphoma. (1985) (27)
Clinical and diagnostic features of 67 cases of hepatocellular carcinoma. (1987) (26)
Alfa-interferon in the treatment of essential thrombocythemia: clinical results and evaluation of its biological effects on the hematopoietic neoplastic clone (1998) (26)
Characteristics of the case mix, organisation and delivery in cancer palliative care: a challenge for good-quality research (2016) (25)
Jaw Avascular Bone Necrosis Associated with Long-Term Use of Bisphosphonates (2006) (25)
Vascular signals from pleura‐based lung lesions studied with pulsed Doppler ultrasonography (1993) (25)
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study. (2015) (24)
Severe immune thrombocytopenic purpura relapse after alpha‐interferon in chronic myeloid leukemia, successfully treated with cyclosporine (1994) (24)
Careful Breakthrough Cancer Pain Treatment through Rapid-Onset Transmucosal Fentanyl Improves the Quality of Life in Cancer Patients: Results from the BEST Multicenter Study (2020) (24)
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study (2021) (23)
Osteonecrosis of the jaw. A newly emerging site-specific osseous pathology in patients with cancer treated with bisphosphonates. Report of five cases and review of the literature. (2007) (23)
Post-traumatic Glioma: Report of two Cases (2006) (22)
Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors. (1994) (22)
Rationale and design of MILES-3 and MILES-4 studies: two randomized phase 3 trials comparing single-agent chemotherapy versus cisplatin-based doublets in elderly patients with advanced non--small-cell lung cancer. (2014) (22)
Capecitabine and Mitomycin c May be an Effective Treatment Option for Third-line Chemotherapy in Advanced Colorectal Cancer (2006) (22)
Meningeal involvement in multiple myeloma: report of a case with cytologic and immunocytochemical diagnosis. (1996) (22)
Ultrasound and ultrasonically guided biopsy in hepatic lymphoma. (1987) (22)
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis. (2019) (21)
Autoimmune thyroid dysfunctions in hematologic malignancies treated with alpha-interferon. (1995) (21)
Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimens. (2015) (21)
Prospective, multicenter, randomized trial of a new organizational modality for providing information and support to cancer patients. (2009) (21)
The Role of Anthracyclines in Combination Chemotherapy for the Treatment of Follicular Lymphoma: Retrospective Study of the Intergruppo Italiano Linfomi on 761 Cases (2003) (21)
Diagnostic aspects and follow-up of 174 cases of hepatocellular carcinoma. Second report. (1991) (21)
Early palliative care and quality of life of advanced cancer patients-a multicenter randomized clinical trial. (2019) (20)
Incidence of SARS-CoV-2 Infection Among Patients Undergoing Active Antitumor Treatment in Italy. (2020) (20)
Prevalence, characteristics, and treatment of fatigue in oncological cancer patients in Italy: a cross-sectional study of the Italian Network for Supportive Care in Cancer (NICSO) (2018) (19)
Trastuzumab-lapatinib as neoadjuvant therapy for HER2-positive early breast cancer: Survival analyses of the CHER-Lob trial. (2021) (18)
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol. (2003) (18)
Position Paper of the Italian Association of Medical Oncology on Early Palliative Care in Oncology Practice (Simultaneous Care) (2017) (18)
Enhanced photosensitizing properties of protein bound curcumin. (2019) (18)
Epithelial alterations adjacent to 111 vulvar carcinomas. (1988) (18)
Hypericin-Apomyoglobin: An Enhanced Photosensitizer Complex for the Treatment of Tumor Cells. (2019) (17)
The Medical Oncologist's Role in Palliative Care: AIOM's Position (2009) (17)
Ultrasound and ultrasonically guided biopsy in oncohematology. (1991) (17)
Diagnostic imaging of primary hepatic leiomyosarcoma: a case report. (1996) (16)
MOPPEBVCAD Chemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin's Lymphoma: 10-Year Results, Late Toxicity, and Second Tumors (2006) (16)
Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy. (2003) (16)
Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (2017) (16)
240 Hepatocellular Carcinomas: Ultrasound Features, Tumor Size, Cytologic and Histologic Patterns, Serum Alpha-Fetoprotein and HBs Ag (1987) (15)
Simultaneous relapse of liver cell carcinoma and non-Hodgkin's lymphoma in the liver. Report of a case with diagnosis by ultrasonically guided fine needle aspiration biopsy. (1994) (15)
Early Integration of Palliative Care in Oncology Practice: Results of the Italian Association of Medical Oncology (AIOM) Survey (2016) (15)
Cancer patients with COVID-19: a retrospective study of 51 patients in the district of Piacenza, Northern Italy (2020) (15)
Prevalence study on potential drug–drug interaction in cancer patients in Piacenza hospital’s Onco-Haematology department (2018) (14)
Validation of the international prognostic index in working formulation group A low-grade non-Hodgkin's lymphoma: retrospective analysis of 137 patients from the Gruppo Italiano per lo Studio dei Linfomi registry. (2000) (14)
Fighting cancer in coronavirus disease era: organization of work in medical oncology departments in Emilia Romagna region of Italy (2020) (14)
Correction to: Can early palliative care with anticancer treatment improve overall survival and patient-related outcomes in advanced lung cancer patients? A review of the literature (2018) (14)
Association of non-Hodgkin's lymphoma and hepatocellular carcinoma. (1990) (14)
Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status. (2018) (14)
Ultrasonically guided fine needle aspiration biopsy (UG-FNAB): a useful technique for the diagnosis of abdominal malignancies. (1986) (13)
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer (2015) (13)
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (2020) (13)
Apomyoglobin is an efficient carrier for zinc phthalocyanine in photodynamic therapy of tumors. (2019) (13)
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up (2021) (13)
Ultrasonically guided percutaneous drainage of abdominal fluid collections: A long-term study of its therapeutic efficacy (2005) (13)
High prevalence of anti-HGV/E2 antibodies in HCV-positive patients with non Hodgkin's lymphoma. (1998) (13)
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG (2020) (13)
Laparoscopic ultrasonography in the study of liver diseases (1989) (12)
Obstructive jaundice secondary to non‐Hodgkin's lymphoma: Usefulness of ultrasound‐guided fine‐needle aspiration biopsy (UG‐FNAB) (1990) (12)
Thoracentesis in advanced cancer patients with severe thrombocytopenia: Ultrasound guide improves safety and reduces bleeding risk (2018) (12)
A pilot study on the use of the proMACE‐cytaBOM regimen as a first‐line treatment of advanced follicular non‐Hodgkin's lymphoma (1997) (12)
Anaplastic myeloma as extramedullary relapse of multiple myeloma in remission. Case report and review of the literature. (1986) (12)
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer. (2019) (12)
Cancer Diagnosis Disclosure in a Northern Italian Hospital Report on 312 Consecutive Cancer Patients (2007) (12)
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial. (2019) (11)
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial (2020) (11)
The challenge of sustainability in healthcare systems: frequency and cost of diagnostic procedures in end-of-life cancer patients (2018) (11)
Advanced Gastric Cancer with Liver and Lymph Node Metastases Successfully Resected after Induction Chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (2015) (11)
Epidoxorubicin vs idarubicin containing regimens in intermediate and high grade non-Hodgkin's lymphoma: preliminary results of a multicentric randomized trial. (1993) (11)
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial (2017) (11)
Impact on Survival of Timing and Duration of Adjuvant Chemotherapy in Radically Resected Gastric Cancer (2016) (11)
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial (2019) (11)
Effects of Thymostimulin with Combination Chemotherapy in Patients with Aggressive Non‐Hodgkin's Lymphoma: A Report from the Italian Lymphoma Study Group (GISL) (1995) (11)
Primary adrenal non-Hodgkin's lymphoma associated with autoimmune hemolytic anemia: a case diagnosed by ultrasound-guided fine needle biopsy. (1999) (11)
Elderly cancer patients’ preferences regarding the disclosure of cancer diagnosis. Experience of a single institution in Italy (2009) (11)
Modified FOLFIRINOX for unresectable locally advanced/metastatic pancreatic cancer. A real-world comparison of an attenuated with a full dose in a single center experience (2019) (11)
Primary pancreatic lymphoma. Report of five cases. (2005) (10)
Bleomycin, Epidoxorubicin, Cyclophosphamide, Vincristine and Prednisone (BACOP) in Patients with Follicular Non-Hodgkin's Lymphoma: Results of a Prospective, Multicenter Study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL) (2002) (10)
Presentation of esophageal cancer with solitary splenic metastasis. (2005) (10)
Hepatocellular carcinoma and B-cell tumors. (1994) (10)
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study (2022) (10)
Colon Carcinoma Metastasis to the Thyroid Gland (2006) (10)
Consensus document of the Italian Association of Medical Oncology and the Italian Society of Palliative Care on early palliative care (2018) (9)
Sonographic appearance and ultrasonically guided biopsy (1990) (9)
Safety and Activity Report of a Randomized Phase II Trial of Preoperative Anthracycline-Based Chemotherapy Plus Lapatinib, Trastuzumab or Both in HER2 Positive Breast Cancer: CHERLOB Trial. (2009) (9)
Return to work after treatment for breast cancer (2011) (9)
Giant cell tumor of bone. (2014) (9)
An Anticancer Drug Unit for the whole provincial oncologic network of Piacenza: improving safety and savings (2015) (9)
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype (2020) (9)
Vulvar intraepithelial neoplasia. A clinicopathologic study of 60 cases. (1990) (9)
Effectiveness of bevacizumab added to gold standard chemotherapy in metastatic colorectal cancer (mCRC): Final results from the Itaca randomized clinical trial. (2013) (9)
Extramedullary Plasmacytoma in a Patient with Aids: Report of a Case and Review of the Literature (1998) (9)
Advanced Waldenström’s Macroglobulinemia: A Case of Possible Cure after Systemic Chemotherapy, Splenic Radiation and Splenectomy (2002) (9)
Peri-lesional injections of granulocyte-macrophage colony-stimulating factor in the management of chronic leg ulcers in type II mixed cryoglobulinemia. (2000) (9)
BCR-ABL rearrangement is not detectable in essential thrombocythemia. (2001) (9)
Rationale and Design of MILES-3 and MILES-4 Studies : Two Randomized Phase 3 Trials Comparing Single-Agent Chemotherapy Versus Cisplatin-Based Doublets in Elderly Patients With Advanced Non e Small-Cell Lung Cancer (8)
Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis (2018) (8)
Low-dose interferon alpha treatment in essential thrombocythemia. (2009) (8)
Dexamethasone‐Sparing Regimens with Oral Netupitant and Palonosetron for the Prevention of Emesis Caused by High‐Dose Cisplatin: A Randomized Noninferiority Study (2021) (8)
Central venous catheterization in cancer patients with severe thrombocytopenia: Ultrasound-guide improves safety avoiding prophylactic platelet transfusion (2020) (8)
Two year follow-up results of the CARDIAC (CARDIomyoplasty by Autologous intraCoronary bone marrow in acute myocardial infarction) randomised controlled trial. (2013) (8)
Vulvar dystrophies in young and premenopausal women. (1988) (8)
Cerebrospinal fluid cytology diagnosis of HER2-positive leptomeningeal carcinomatosis from HER2-positive metastatic gastric cancer: case report. (2011) (8)
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer (2021) (8)
Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer (ERIGE trial). Clinical and pharmacogenetic results on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC). (2019) (7)
Diagnostic Accuracy of a New Tumor Serologic Marker, CA 19-9: Comparison with CEA (1986) (7)
Addition of bevacizumab to erlotinib as first-line treatment of patients with EGFR-mutated advanced nonsquamous non-small cell lung cancer. The BEVERLY multicenter randomized phase III trial. (2022) (7)
Feasibility of a trial with Tibetan Singing Bowls, and suggested benefits in metastatic cancer patients. A pilot study in an Italian Oncology Unit (2016) (7)
1207O Bevacizumab + erlotinib vs erlotinib alone as first-line treatment of pts with EGFR mutated advanced non squamous NSCLC: Final analysis of the multicenter, randomized, phase III BEVERLY trial (2021) (7)
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy (2020) (7)
Efficacy of the addition of cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicenter, randomized phase III MILES-3 and MILES-4 studies. (2017) (7)
Cellular atypia in vulvar dystrophies. (1988) (7)
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial. (2017) (7)
A pilot study on the use of the ProMACE-CytaBOM regimen as a first-line treatment of advanced follicular non-Hodgkin's lymphoma. Gruppo Italiano per lo Studio dei Linfomi. (1997) (7)
Preplanned first-step analysis of LET-LOB neoadjuvant study: A double-blind randomized phase IIb trial of letrozole (L) plus lapatinib (Lp) or placebo (P) in postmenopausal HER2-ve, HR+ve operable breast cancer. (2009) (7)
Novel BRAF mutation in melanoma: A case report. (2018) (7)
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease. (2000) (7)
PAM50 HER2-enriched subtype as an independent prognostic factor in early-stage HER2+ breast cancer following adjuvant chemotherapy plus trastuzumab in the ShortHER trial. (2019) (6)
Ultrasonically guided fine needle aspiration biopsy of abdominal lesions in pathological staging of non-Hodgkin's lymphomas. (1985) (6)
CHER-LOB: PREOPERATIVE CHEMOTHERAPY PLUS TRASTUZUMAB, LAPATINIB OR BOTH IN HER2-POSITIVE OPERABLE BREAST CANCER – PRELIMINARY SAFETY REPORT WITH FOCUS ON CARDIAC TOLERABILITY (2007) (6)
Prevalence of COVID-19 Infection in Asymptomatic Cancer Patients in a District With High Prevalence of SARS-CoV-2 in Italy (2021) (6)
CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL). (1996) (6)
Extramedullary plasmacytoma of the testicle (1990) (6)
CHER LOB Trial: Preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer—Safety report as per Independent Data Monitoring Committee (IDMC) and preliminary activity data (2008) (6)
Primary dural lymphoma mimicking a chronic epidural hematoma. Differential diagnosis of two rare conditions (2013) (6)
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern (2022) (6)
Malignant pleural mesothelioma metastatic to the submandibular salivary gland, simulating glandular hypertrophy, diagnosed by fine-needle aspiration biopsy: a case report and literature review (2014) (5)
Primary squamous cell carcinoma of the breast after cured bilateral breast cancer. (2014) (5)
Angioimmunoblastic Lymphadenopathy with Disproteinemia Associated with Carcinoma (1988) (5)
Central venous catheter care for the patients with cancer: ultrasound-guided insertion should be strongly recommended for internal jugular vein catheterization. (2013) (5)
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial. (2021) (5)
The Interaction of Hypericin with SARS-CoV-2 Reveals a Multimodal Antiviral Activity (2022) (5)
Complications of ultrasound-guided fine-needle biopsy of the spleen: Report on 110 patients and review of the literature (1996) (5)
Color-Doppler in the imaging work-up of primary hyperparathyroidism. (1999) (5)
Targeted photoimmunotherapy for cancer (2022) (5)
Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials. (2019) (5)
Sweet's syndrome associated with monosomy 7 myelodysplastic syndrome. (2001) (5)
P2.06-017 Amethyst NSCLC Trial: Phase 2 Study of MGCD265 in Patients with Advanced or Metastatic NSCLC with Activating Genetic Alterations in MET: Topic: Phase II + NK (2017) (5)
Mediterranean Diet Affects Blood Circulating Lipid-Soluble Micronutrients and Inflammatory Biomarkers in a Cohort of Breast Cancer Survivors: Results from the SETA Study (2021) (4)
Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC) (2004) (4)
Clinical efficacy of ultrasound guided percutaneous drainage of abscesses in patients with leukaemia and lymphoma. (1998) (4)
Herpes Zoster Following COVID-19 Vaccination in Long-Term Breast Cancer Survivors (2021) (4)
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio. (2018) (4)
41O Nine weeks vs 1-year adjuvant trastuzumab: Long term outcomes of the ShortHER randomised trial (2021) (4)
COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety (2022) (4)
Lapatinib or placebo plus letrozole as preoperative treatment of hormone receptor-positive HER2-negative operable breast cancer. Preliminary report of safety and activity of the double-blind randomized phase IIb LET-LOB study (2008) (4)
Splenic lesions in Hodgkin's and non-Hodgkin's lymphomas. An ultrasonographic study (1995) (4)
Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer. (2017) (4)
Feasibility and Utility of Incorporating Patient-Reported Outcomes into Surveillance Strategies for Advanced Lung Cancer (2020) (4)
Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S (2020) (4)
Amethyst NSCLC trial: Phase 2, parallel-arm study of receptor tyrosine kinase (RTK) inhibitor, MGCD265 in patients with advanced or metastatic non-small cell lung cancer (NSCLC) with activating genetic alterations in mesenchymal-epithelial transition factor (MET) (2016) (4)
Does ultrasonically guided biopsy modify indications to laparoscopy in hepatology (1987) (4)
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial. (2021) (4)
Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy (2022) (4)
A singular case of multiple myeloma and primary biliary cirrhosis strictly associated in pathogenesis and response to alkylating therapy (2006) (4)
Nab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial (2019) (3)
Hepatocellular carcinoma associated with other primary malignancies. (1990) (3)
Oxaliplatin (OXA), 5-fluorouracil (5-FU) and leucovorin (LV) in patients with advanced or metastatic gastric cancer (A/MGC). (2004) (3)
Mediterranean Diet influences breast cancer relapse: preliminary results of the SETA PROJECT. (2016) (3)
Nodular intracerebral leukemic involvement in the course of acute nonlymphocytic leukemia. Case report and review of the literature. (1989) (3)
Correlation between NDRG1 gene polymorphism and neuropathy (N) in metastatic breast cancer (MBC) patients (pts) enrolled in the PAINTER study (Polymorphism And INcidence of Toxicity in ERibulin treatment). (2019) (3)
Idarubicin plus attenuated high‐dose cytosine arabinoside in the treatment of relapsed and refractory acute leukemia (1990) (3)
Triple negative endometrial cancer: Incidence and prognosis in a monoinstitutional series of 220 patients. (2020) (3)
Rituximab in Combination with Interferon-Alpha in Relapsed and Refractory Diffuse Large B-Cell Non-Hodgkin’s Lymphoma (2001) (3)
19P PIK3CA mutations in HER2-positive early breast cancer patients enrolled in the adjuvant randomized short-HER study (2020) (3)
Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies. (2017) (3)
Reduction of fear and acute toxicity from chemotherapy with a telephone call after the first cycle. (2013) (3)
A multicenter randomized trial of two different proMACE-cytaBOM derived protocols in aggressive non-hodgkin's lymphomas (NHL). A preliminary report (1992) (3)
Aprepitant versus metoclopramide, both combined with dexamethasone, for preventing cisplatin-induced delayed emesis: A randomized, double-blind study. (2014) (3)
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study (2021) (3)
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study (2021) (3)
Low-dose cytosine arabinoside in the treatment of acute nonlymphocytic leukemia. (1988) (3)
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study. (2015) (3)
Human Herpesvirus 6 Encephalitis Simulating Brain Metastases in a Patient with Advanced Small-Cell Lung Cancer (2014) (2)
Letter to the Editor: Panax Ginseng for Cancer-Related Fatigue. (2018) (2)
Oncologic Emergencies Secondary to Advanced Colorectal Cancer Successfully Treated with Oxaliplatin/5-Fluorouracil/Leucovorin: Report of Three Cases (2005) (2)
One day surgery in breast cancer patients: Safe and feasible procedure (2008) (2)
S10Incidence, characteristics and treatment of fatigue in oncological cancer patients (pts) in italy: a cross-section study (2016) (2)
Parental origin of chromosomes 9 and 22 involved in the Ph chromosome translocation in chronic myelocytic leukemia. (1998) (2)
Acute Myelocytic Leukemia and Chronic Myelomonocytic Leukemia Simultaneously with Resectable Breast Cancer: A Report of two Cases (1992) (2)
Primary lung lymphoma. (2004) (2)
[Thrombotic thrombocytopenic purpura: report of seven cases]. (2005) (2)
Imatinib-Related Neutropenia in Chronic-Phase Chronic Myelogenous Leukaemia: Safety and Efficacy of Granulocyte-Colony-Stimulating Factor (Filgrastim) Use. (2005) (2)
COVID-19 Outbreak in Italy: Report on the First 124 Consecutive Patients Treated at Home. (2021) (2)
[Job loss and return to work of patients with cancer. A prospective observational study on 416 cancer patients.] (2019) (2)
1697P Cancer patients’ perceptions, opinions and feelings during the COVID-19 epidemic in the most affected Italian areas: Serial cross-sectional study (2020) (2)
Angioimmunoblastic lymphadenopathy with disproteinemia associated with carcinoma. Case report and review of the literature. (1988) (2)
Oral Prolonged‐Release Oxycodone‐Naloxone: Analgesic Response, Safety Profile, and Factors Influencing the Response in Patients With Advanced Cancer (2019) (2)
Echo doppler analysis of lymphomatous lymph nodes (1990) (2)
[The treatment of cancer patients near their residence in the territorial structure "Casa della salute": preliminary results in the province of Piacenza (Italy).] (2018) (2)
Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature (2023) (2)
Anthracycline-based preoperative chemotherapy plus lapatinib and trastuzumab or both in HER2-positive breast cancer: Preliminary cardiac safety report of the CHER LOB trial. (2009) (2)
In vivo biological response following low‐dose interleukin‐2 in complete remission B‐cell non‐Hodgkin's lymphoma patients (1996) (2)
Ultrasound-guided Central Venous Catheterization for Home Parenteral Nutrition and Hydratation in Advanced Incurable Cancer Patients: Results of A Prospective Observational Study (2011) (2)
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study (2021) (2)
Oral idarubicin and prednisone for advanced, previously untreated, multiple myeloma: a pilot study. Cooperative Group of Study and Treatment of Multiple Myeloma. (1996) (2)
Ultrasound guidance of central venous catheterization: towards a zero risk of iatrogenic pneumothorax. (2010) (2)
Phase II study of NAB-paclitaxel in sensitive and refractory relapsed SCLC (NABSTER TRIAL). (2018) (2)
Metronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): What has changed over the time? Preliminary results of the VICTOR-6 study (2017) (2)
Survival analysis of the prospective randomized Cher-Lob study evaluating the dual anti-HER2 treatment with trastuzumab and lapatinib plus chemotherapy as neoadjuvant therapy for HER2-positive breast cancer (BC). (2020) (2)
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer (2021) (2)
Efficacy and safety of ultrasound-guided central venous access in oncological and haematological patients: Results of a monocenter series of 519 consecutive patients (2005) (2)
LET-LOB: preoperative letrozole plus lapatinib or placebo in hormone-receptor positive HER2 negative operable breats cancer. Preliminary report of activity and cardiac tolerability (2007) (2)
Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study. (2016) (2)
Erratum: The promher study: An observational Italian study on adjuvant therapy for her2-positive, pt1a-b pn0 breast cancer stefania gori (PLoS ONE (2015) 10:9 (e0139650) DOI: 10.1371/journal.pone.0139650) (2015) (2)
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey (2023) (1)
800TiP Meet-URO 12: A randomized phase II trial of niraparib versus best supportive care (BSC) as maintenance treatment in patients with locally advanced or metastatic urothelial cancer (UC) whose disease did not progress after completion of first-line platinum-based chemotherapy (2020) (1)
Imaging of solitary necrotic nodule of the liver. Report of one case (1994) (1)
COVID-19 outbreak in Italy. Report of 20 cancer patients with COVID-19 treated at home during the first wave (2021) (1)
Predictive Factors for Outcome of First Allogeneic Transplant for Elderly Patients With Acute Lymphoblastic Leukemia. (2021) (1)
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial (2022) (1)
Small (≤3 cm) hepatic lesions (2005) (1)
Erratum to "Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life" [Eur J Cancer 69 (2016) 110-118]. (2017) (1)
Inversion time prolongation at late enhancement cardiac MRI in a myeloma patient. (2012) (1)
Ultrasonically Guided Percutaneous Biopsy of the Spleen (1992) (1)
Screening for Distress in Everyday Oncology Practice (2016) (1)
Randomised clinical trials on outpatient treatment of SARS‐COV‐2 infection: Light and shadows (2021) (1)
A05Effect of Mediterranean Diet on the prevalence of breast cancer relapse: preliminary results of the “SETA PROJECT” (2015) (1)
Erratum: Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer (British Journal of Cancer (2004) 92 (24-29) DOI: 10.1038/sj.bjc.6602276) (2005) (1)
CIRRHOSIS of the liver. (1946) (1)
Carcinoma of the esophagus in a hemophiliac infected with the human immunodeficiency virus. (1989) (1)
Autologous Bone-Marrow Stem Cell Support in Acute Anterior Myocardial Infarction. (2007) (1)
palliative careEvaluation of effects of early palliative care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial (2016) (1)
[Echographically guided, percutaneous, fine-needle puncture in the diagnosis of renal masses suspected of malignancy]. (1986) (1)
A photosensitizing fusion protein with targeting capabilities (2022) (1)
US-Guided Fine Needle Biopsy of Focal Liver Lesions and Hepatocellular Carcinoma (1992) (1)
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study (2022) (1)
Erratum to: Tumor-infiltrating lymphocytes and molecular response after neoadjuvant therapy for HR+/HER2− breast cancer: results from two prospective trials (2017) (1)
A multicenter, randomised, phase III trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients. The STAD-1 trial. (2015) (1)
Returning to work after treatment for breast cancer. (2011) (1)
Safety of hydroxychloroquine in patients with COVID-19. The experience in the district of Piacenza. Preliminary data. (2020) (1)
ProMACE-cytaBOM versus MACOP-B in intermediate and high grade NHL. Preliminary results of a prospective randomized trial. (1991) (1)
Preliminary safety data of preoperative chemotherapy plus trastuzumab, lapatinib or both in HER2-positive operable breast cancer (2007) (1)
Psoriasiform dermatitis and hepatocellular carcinoma: a new case of Bazex syndrome. (2015) (1)
COVID-19 outbreak in Italy: Clinical-radiological presentation and outcome in three oncologic patients (2020) (1)
HER2-positive gastric cancer showing marked thickening of the gastric wall on ultrasonographic and computed tomographic scans. a chance phenomenon or a specific behaviour of this cancer type? Report of three cases. (2014) (1)
Solitary fibrous tumors of the pleura: a case report and review of the literature. (2013) (1)
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey (2023) (1)
A Rare Case of Coronavirus Disease 2019 Survival in an Elderly Patient With Atheroembolic Renal Disease (2021) (1)
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study (2022) (1)
Peripherally Inserted Central Catheters-Improving Appropriateness With a Dedicated and Rigorous Team. (2016) (1)
P12Distance as a barrier to cancer diagnosis and treatment: review of the literature (2015) (1)
1365PEffect on quality of life (QOL) of adding cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicentre, randomized, phase 3 MILES-3 and MILES-4 studies (2017) (1)
Re: The first report on coronavirus disease 2019 vaccine refusal by patients with cancer in Italy: Early data from a single-institute survey (2021) (1)
Primary and secondary glomerulonephritis I (2012) (1)
Characteristics and outcomes of five patients with COVID‐19 and hematological malignancies (2021) (1)
Tachyarrhythmia secondary to cardiac metastasis as first presentation of non‐small‐cell lung cancer (2012) (1)
Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care Professionals. (2023) (1)
Ultrasound image of massive inferior vena cava thrombosis causing asymptomatic subclinical disseminated intravascular coagulation. (1998) (1)
Intrapleural Trastuzumab Therapy for Malignant Pleural Effusion from HER2 Overexpression in Metastatic Gastric Cancer (2015) (1)
T-cell Subsets Defined by Monoclonal Antibodies in Monoclonal Gammopathy of Undetermined Significance (Mgus) (1985) (1)
PD05-01: Trans-CHER-Lob: A Biomarker Analysis of the Randomized Phase II Study of Neoadjuvant Chemotherapy Plus Trastuzumab, Lapatinib or Combined Trastuzumab and Lapatinib in HER2 Positive Operable Breast Cancer. (2011) (1)
ALK positive lymphohistiocytic variant of anaplastic large cell lymphoma in an adult. (2001) (1)
N08Mood and distress in cancer patients after Autogenic Training (AT): a pilot study in an Italian Oncologic Unit (2016) (1)
Subject Index, Vol. 76, 1986 (1986) (0)
Humoral and cell-mediated immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with cancer on active treatment: Focus on wild type, Delta and Omicron strains. (2022) (0)
Randomized phase III trial of gemcitabine and cisplatin versus gemcitabine alone in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) 2: CAPPA-2 study. (2017) (0)
Efficacy and safety of echoguided catheterisation approach in oncological and hematological patients. Report on 843 consecutive patients (2007) (0)
Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA (2022) (0)
B25Gastrointestinal stromal tumors associated with other malignancies. Chance phenomenon or causal relationship? A series of 75 patients (2016) (0)
TRENDS AND SOCIO-ECONOMIC INEQUALITIES IN CANCER SURVIVAL OF PATIENTS WITH HODGKIN’S DISEASE DIAG- NOSED IN ENGLAND AND WALES BETWEEN 1986 AND 1999 (2005) (0)
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) (2010) (0)
Risk assessment of admission procedures for cancer patients during the convalescence of COVID-19 Incidence of in ﬂ uenza-like illness (ILI) in cancer patients during COVID-19: The ONCOVID prospective observational study (2020) (0)
1337P Implementation of precision oncology in clinical practice: A nationwide survey in Italy (2022) (0)
A 98-Year-Old Male With Paroxysmal Atrial Fibrillation Treated for COVID-19 at Home (2022) (0)
Role of visceral pleural invasion and tumor sizing at CT of resected NSCLC in clinical-radiological and pathological T agreement (2022) (0)
MEDICAL THERAPY OF VULVAR DYSTROPHIES. OUR PROTOCOL. (1987) (0)
Abstract P5-18-05: The Promher Study: An observational Italian study on HER2+ve, pT1a-b, pN0, M0 breast cancer (BC) patients (pts) (2015) (0)
Contents, Vol. 76, 1986 (1986) (0)
D09Circulating pro-angiogenic markers in patients receiving first-line FOLFIRI + Bevacizumab. The SENTRAL (Serum angiogenesis-cENTRAL) pre-planned analysis of the Italian Research Group for Digestive Tract Cancer (GISCAD) CENTRAL trial (ColorEctalvastiNTRiAlLdh) (2016) (0)
We treat patients and we do not treat disease. (2001) (0)
Brain metastastasis in human epidermal growth factor 2 (HER-2) overexpression gastric cancer. (2015) (0)
"I have a cancer, I am ill, it's Sunday, my oncologist is not here, I am despairing." How a telephone call can resolve a great difficulty of cancer patients. (2017) (0)
PROM_A_179185 49..66 (2020) (0)
Autologous hematopotoietic stem cell transplantation in multiple sclerosis with an intermediate intensity conditioning regimen : the Italian multi-centre experience (2011) (0)
Use of ultrasound-guided thoracentesis to reduce iatrogenic risk of pneumothorax in patients with cancer. (2011) (0)
A new docetaxel (DOC)-based triplet regimen does not improve the outcome of metastatic (M) or locally advanced (LA) gastric cancer (GC) as compared with an epirubicin (EPI) standard triplet regimen: A GISCAD trial (2019) (0)
[Natural history of active chronic hepatitis. Case contribution]. (1986) (0)
PO75 RETROSPECTIVE ANALYSIS OF ADVANCED LUMINAL BREAST CANCER PATIENTS TREATED WITH ENDOCRINE THERAPY (ET) ANDPALBOCICLIBWITHINACOMPASSIONATE USE PROGRAMME (2017) (0)
The HERBA trial: a retrospective study on patients (pts) with HER2-positive (HER2+ve) breast cancer (BC) and brain metastases (BMs). (2017) (0)
Abstract OT2-19-06: Phase 2 study of abemaciclib in combination with endocrine therapy with or without paclitaxel induction in patients with hormone receptor-positive, HER2-negative advanced breast cancer and aggressive disease criteria: ABIGAIL (2022) (0)
[Clinical and therapeutic aspects of Hodgkin's disease involving gastro-intestinal tract. A study of 7 cases (author's transl)]. (1979) (0)
Internet in oncology: a new way to improve communication and information? (2017) (0)
Poor prognosis of triple negative phenotype in endometrial cancer patients. (2016) (0)
Phase 2 study of second-line FOLFIRI-aflibercept in prospectively stratified, RAS wild type, anti-EGFR resistant, metastatic colorectal cancer patients: The DISTINCTIVE trial. (2021) (0)
One-day surgery in breast cancer: Monoinstitutional results (experience during 2. 5 years). (2009) (0)
Diagnosis of pancreatic neoplasia (2012) (0)
Abstract OT3-02-05: Phase II study of eribulin in combination with gemcitabine for the treatment of patients with locally advanced or metastatic triple negative breast cancer. ERIGE Trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC) (2016) (0)
R10Painting the pain (2016) (0)
[Home care: home venous access device insertion during covid-19 pandemic in not autonomous patients. From an emergency activity to a daily work practice.] (2022) (0)
L28Central Nervous System metastastasis in gastric or gastro-esophageal junction cancer, correlation with human epidermal growth factor 2 (HER-2) status (2015) (0)
Abstract P5-14-01: Eribulin tolerability and correlation between neuropathy and a set of polymorphisms in metastatic breast cancer patients. Results from the PAINTER (Polymorphism And Incidence of Toxicity in ERibulin treatment) study (2020) (0)
5149 Randomized phase II trial of preoperative chemotherapy plus lapatinib, trastuzumab or both in HER2 positive breast cancer: results of the first step simon's design (2009) (0)
B36FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution experience (2016) (0)
P-0268 Notch and DLL4 Expression in Colon Cancer Patients Treated with Bevacizumab (2012) (0)
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (2020) (0)
Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial. (2018) (0)
Association of high volume center with survival for glioblastoma patients: Results from a prospective population-based registry (PERNO). (2014) (0)
Metronomic Chemotherapy (mCHT) in HER2-ve Advanced Breast Cancer (ABC) Patients (PTS): When Care Objectives Meet Patients’ Need. Preliminary Results of the Victor-6 Study (2017) (0)
Quality of end of life care in patients with pancreatic cancer receiving systematic versus on-demand early palliative care at diagnosis: a secondary outcome analysis from a randomized controlled trial. (2017) (0)
560PIMPACT OF PRE-TREATMENT LACTATE DEHYDROGENASE (LDH) LEVELS ON PROGNOSIS AND BEVACIZUMAB EFFICACY IN ADVANCED COLORECTAL CANCER PATIENTS. (2014) (0)
BOOST: a phase 3 trial of sorafenib vs. best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function (2021) (0)
[Colposcopic investigation of 62,258 subjects. Clinico-statistical considerations]. (1986) (0)
R51Thoracentesis in cancer patients with severe thrombocytopenia: ultrasound guide improves safety (2015) (0)
Distance from hospital in clinical practices. (2017) (0)
Incidence, characteristics and treatment of fatigue in oncological cancer patients (PTS) in Italy: A cross-sectional study. (2016) (0)
M04*Peripherally inserted central venous catheters (PICCs) in cancer patients placed by specialist nurses. A prospective observational study of 817 consecutive catheterizations (2015) (0)
Evaluation of dexamethasone (DEX)-sparing regimens, administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) in older patients receiving high-dose cisplatin (2021) (0)
301PMetronomic chemotherapy (mCHT) in HER2-ve advanced breast cancer (ABC) patients (pts): Old drugs, new opportunities Preliminary results of the VICTOR-6 study (2017) (0)
Real-world guideline application in the management of pancreatic cancer patients: the Italian GARIBALDI study. (2019) (0)
Gastrointestinal involvement in non-Hodgkin's lymphoma. Report of 26 patients. (1984) (0)
THORACIC AND PULMONARY INVOLVEMENT BY MULTIPLE MYELOMA. SONOGRAPHIC APPEARANCE AND ULTRASONICALLY‐GUIDED BIOPSY (1989) (0)
Hepatitis C and B-cell non-Hodgkin’s lymphoma: a geographicallyvariable association? (2000) (0)
Phase II randomised clinical study of metformin plus chemotherapy vs chemotherapy alone in HER2 negative metastatic breast cancer: final results of the MYME trial (2016) (0)
for a simple binary classification with clinical and investigational Study of prognosis in Waldenstrom's macroglobulinemia: a proposal (2011) (0)
M10A computerized approach for the management of peripheral and central venous accesses (2015) (0)
Abstract P5-12-05:9Weeks vs 1 Year Adjuvant Trastuzumab in Combination with Chemotherapy: Preliminary Cardiac Safety Data of the Phase III Multicentric Italian Study Short-HER (2010) (0)
Abstract 4646: Notch and DLL4 expression in bevacizumab-treated colon cancer patients. (2013) (0)
Association between insulin-like growth factor-1 receptor (IGF1R) expression in circulating tumor cells (CTCs) and prognosis in patients with metastatic breast cancer (MBC). (2017) (0)
M26Midline for apheresis of peripheral blood stem cells (2015) (0)
Bedside Peripheral Ultrasound-Guided Vascular Access in 253 Patients Hospitalized With COVID-19 Pneumonia: A Retrospective Italian Study (2022) (0)
Contents Vol. 60, 2014 (2015) (0)
[Cardioinhibitory carotid sinus syndrome: Holter monitoring does not change the clinical selection of patients for treatment]. (1985) (0)
Abstract PS5-14: Gene-expression profiling and response to neoadjuvant endocrine treatment in the phase II LETLOB trial (2021) (0)
Prognostic Impact of Ras Mutation on Surgical Strategy in Rectal Cancer Patients Undergoing Neoadjuvant Treatment (2023) (0)
Immune microenvironment and intrinsic subtyping in hormone receptor-positive/HER2-negative breast cancer (2021) (0)
Surgery and the elderly: when an apparent overtreatment becomes safe and effective. (2017) (0)
A randomized phase II trial of maintenance oral metronomic vinorelbine versus close observation in advanced non-small cell lung cancer (NSCLC) following platinum-based chemotherapy: MA.NI.LA. trial. (2018) (0)
The Role of Antiviral Treatment in Hepatitis C Virus (HCV)-Related Non-Hodgkin Lymphoma: An Update of a Multicenter Study. (2005) (0)
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the Italian Research Group for Digestive Tract Cancer (GISCAD) CENTRAL (ColorEctalvastiNTRiAlLdh) and SENTRAL (Serum angiogenesis-cENTRAL) analysis. (2016) (0)
Peripheral B and T-cell subsets defined by monoclonal antibodies in patients treated with histamine type-2 receptor antagonists. (1984) (0)
M07Tunnelled peripherally Inserted Central Catheters (2015) (0)
A study of T lymphocyte subpopulations by monoclonal antibodies in a case of angio-immunoblastic lymphadenopathy with dysproteinemia. (1983) (0)
Patient-caregiver relationship in cancer fatigue and distress. A dyadic approach (2022) (0)
H13Midline for home palliative care (2016) (0)
Results, Late Toxicity, and Second Tumors Radiotherapy in Advanced Hodgkin's Lymphoma: 10-Year MOPPEBVCAD Chemotherapy with Limited and Conditioned (2006) (0)
[Natural history of 45 patients with active chronic hepatitis in a general medicine unit]. (1985) (0)
Clinical experiences with emergency ultrasound guided diagnostic and therapeutic procedures in a department of internal medicine. (1999) (0)
LETTERS AND CORRESPONDENCE (2006) (0)
P30.02 Assessing SIADH (Syndrome of Inapproriate Antidiuretic Hormone Secretion) Management and Outcome Among Lung Cancer Patients: The Assert Trial (2021) (0)
Solitary Fibrous Tumors of the Pleura: A Case Report and Review of the Literature (2013) (0)
459 Cardiac study. effect of autologous intracoronary mononuclear bone marrow cell transplantation in humans in patients after acute anterior myocardial infarction with left ventricular dysfunction (2008) (0)
E01*Effects of simultaneous care on quality of life of advanced cancer patients. A multicenter controlled randomised clinical trial (2016) (0)
Gastrointestinal metastasis from breast cancer: Report of five patients from a retrospective analysis of 740 cases at a single institute and review of the literature. (2011) (0)
[Condylomata acuminata and vulvar intraepithelial neoplasms (VIN)]. (1988) (0)
Analysis of circulating biomarkers in a randomized phase II trial of maintenance oral metronomic vinorelbine in advanced NSCLC following platinum-based chemotherapy: A correlative MA.NI.LA. trial study. (2018) (0)
MOPPEBVCADChemotherapy with Limited and Conditioned Radiotherapy in Advanced Hodgkin ’ s Lymphoma : 10-Year Results , LateToxicity , and SecondTumors (2006) (0)
N14Screening for distress in everyday oncology practice (2016) (0)
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line (2023) (0)
E03Prevalence study on potential drug-drug interaction in piacenza hospital onco-haematology department (2016) (0)
FOLFIRINOX for unresectable locally advanced / metastatic pancreatic cancer . A real-world comparison of an attenuated with a full dose in a single center experience (2019) (0)
Abstract PS10-50: Patterns of use of a trastuzumab biosimilar (ABP 980) in patients with HER2+ breast cancer treated in clinical practice in Europe: An interim analysis from an observational chart review study (GARDENIA) (2021) (0)
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer. (2011) (0)
R18Osteopathy for Post-Mastectomy Pain Syndrome (PMPS) in early breast cancer (EBC) patients: a pilot study in an Italian Oncology Unit (2016) (0)
An open-label, randomized phase III study of early switch maintenance vs delayed second-line nivolumab in advanced stage squamous non-small cell lung cancer (NSCLC) patients after standard first-line platinum-based chemotherapy: EDEN trial. (2019) (0)
H09The home self-monitoring of symptoms after chemotherapy in cancer patients with the use of ESAS scale (2016) (0)
On the need of biopsy confirmation at suspected first recurrence of cancer. (2004) (0)
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL) (2021) (0)
Behind the disease, inside to the illness (2014) (0)
HHV-8 infection in blood donors and patients with malignant and reactive lymphoproliferations from different regions of Italy (1998) (0)
1562P Observational prospective study of Italian guidelines application for patients with pancreatic ductal adenocarcinoma (2020) (0)
CCNU , VINBLASTINE , PROCARBAZINE AND PREDNISONE (2005) (0)
E12Psychological and physical benefits in metastatic cancer patients using Tibetan Singing Bowls. A pilot study in an Italian Oncology Unit (2016) (0)
607PBODY MASS INDEX AND BEVACIZUMAB-BASED THERAPY IN ADVANCED COLORECTAL CANCER PATIENTS: EVALUATION OF CLINICAL OUTCOME. (2014) (0)
Antiviral treatment in Hepatitis C Virus (HCV)- related low grade non-Hodgkin lymphoma: An update of a multicenter study. (2006) (0)
[Absence of liver hematoma after transcutaneous hepatic puncture biopsy in 181 patients: echographic study]. (1988) (0)
[Cervical intraepithelial neoplasia caused by human papillomavirus infection. Cytomorphologic, colposcopic and immunohistochemical correlations]. (1988) (0)
How to improve the hospital stay in the oncologic patients. (2005) (0)
Evaluating the impact of chemotherapy-induced nausea and vomiting on daily functioning in patients receiving dexamethasone-sparing antiemetic regimens with NEPA (netupitant/palonosetron) in the cisplatin setting: results from a randomized phase 3 study (2022) (0)
[Diagnosis of vulvar dystrophy]. (1986) (0)
Gallbladder sludge after Ceftriaxone therapy. Cas report and literature review (1993) (0)
Ultrasonic findings in gastric lymphoma: Comparing patients with and without AIDS (1991) (0)
Role of Guided - Fine Needle Biopsy of the Pancreatic Lesion (2012) (0)
Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer (2015) (0)
The thermometer of distress in oncology. (2017) (0)
1815MO Two simplified dexamethasone (DEX)-sparing regimens with NEPA for the prevention of emesis caused by cisplatin (DDP): A phase III, controlled, non-inferiority trial (2020) (0)
H05*Peripherally Inserted Central Catheter: it is really time for intracavitary electrocardiography (2016) (0)
Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). (2023) (0)
Natural history of glioblastoma in the modern era: Longitudinal results from a large prospective Italian register. (2012) (0)
H03*The red thread between Piacenza and the Michigan Appropriateness guide for intravenous catheters guidelines (2016) (0)
Exploratory analysis of the effect of a dexamethasone-sparing regimen for prophylaxis of cisplatin-induced emesis on food intake (LUNG-NEPA study) (2023) (0)
P-283Impact of second-line cetuximab-containing therapy in patients with KRAS wild type metastatic colorectal cancer: results from ITACa trial (2015) (0)
Abstract P1-13-02: Withdrawn (2018) (0)
ASSERT: A prospective, observational study measuring sodium improvement and outcomes in patients treated for moderate to severe hyponatremia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH) in Italy (lung cancer cohort) (2019) (0)
N31Redefining the pathways of care: the patient journey (2015) (0)
The Nurses Group Poster Session (2016) (0)
H01*A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial (2015) (0)
1021 The role of hepatitis C virus (HCV) treatment in HCV-related B-cell non-Hodgkin's lymphoma (NHL) (2003) (0)

This paper list is powered by the following services:

Other Resources About Luigi Cavanna

en.wikipedia.org

What Schools Are Affiliated With Luigi Cavanna?

Luigi Cavanna is affiliated with the following schools:

Luigi Cavanna's Academic­Influence.com Rankings